posted on 2020-07-06, 15:05authored byZachary
J. Butz, Kanda Borgognoni, Richard Nemeth, Zach N. Nilsson, Christopher J. Ackerson
A selenium
nanoparticle binding peptide was isolated from a phage
display library and genetically fused to a metalloid reductase that
reduces selenite (SeO<sub>3</sub><sup>2–</sup>) to a Se<sup>0</sup> nanoparticle (SeNP) form. The fusion of the Se binding peptide
to the metalloid reductase regulates the size of the resulting SeNP
to ∼35 nm average diameter, where without the peptide, SeNPs
grow to micron sized polydisperse precipitates. The SeNP product remains
associated with the enzyme/peptide fusion. The Se binding peptide
fusion to the enzyme increases the enzyme’s SeO<sub>3</sub><sup>2–</sup> reductase activity. Size control of particles
was diminished if the Se binding peptide was only added exogenously
to the reaction mixture. The enzyme-peptide construct shows preference
for binding smaller SeNPs. The peptide–SeNP interaction is
attributed to His based ligation that results in a peptide conformational
change on the basis of Raman spectroscopy.